Illumina, Inc. vs iShares Russell 2000 ETF — how do they compare? Illumina, Inc. trades at $193.3 (market cap $29.12B), while iShares Russell 2000 ETF trades at $302.75. The key difference: iShares Russell 2000 ETF is trading nearer its 52-week high, Illumina, Inc. nearer its low. Which is the better fit depends on your goals.
| ILMN | IWM | |
|---|---|---|
Market Cap | $29.12B | — |
Sector | Health | — |
52-Week High | $205.10 | $301.69 |
52-Week Low | $91.00 | $225.45 |
Enterprise Value | $30.48B | — |
Trailing returns across standard periods
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →The ETF is designed to track the performance of the securities and the stocks in the Russell 2000 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on IWM →